Verinurad

DB11873InvestigationalSmall molecule

Verinurad has been used in trials studying the basic science and treatment of Gout, Gout and Hyperuricemia, and Gout and Asymptomatic Hyperuricemia.

Mechanism: Pharmacologically active on Solute carrier family 22 member 12
Curator reviewed
Formula / weight: C₂₀H₁₆N₂O₂S · 348.42 g/mol (avg)
Code names: RDEA-3170

Resolves to

Compound

Structure

InChIKeyYYBOLPLTQDKXPM-UHFFFAOYSA-NSMILESCC(C)(SC1=CC=NC=C1C1=C2C=CC=CC2=C(C=C1)C#N)C(O)=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Drug interactionsStructured to mechanism, not free text

12Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Verinurad, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.